Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Women who had bariatric surgery risk nutritional deficiencies causing skin issues during pregnancy and breastfeeding.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Children with cancer had slightly more unusual facial shapes than healthy kids, but not enough to easily tell them apart.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

Hair follicles could be used to deliver drugs effectively, with the right understanding and methods.

More research is needed before using brown fat to treat polycystic ovary syndrome.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Microspheres about 1.5 micrometers in size can best penetrate hair follicles, potentially reaching important stem cells.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The research shows that a gene called Wnt3 affects hair growth and structure, causing short hair and balding when overactive.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.